logo
Second-Line Treatment of Non-small Cell Lung Cancer: Big Targets, Small Progress; Small Targets, Big Progress?
MicroRNA in Lung Cancer
Establishment and Expression Profiling of New Lung Cancer Cell Lines from Chinese Smokers and Lifetime Never-Smokers
Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer
Size of Metastatic and Nonmetastatic Mediastinal Lymph Nodes in Non-small Cell Lung Cancer
A Clinical Prediction Rule to Estimate the Probability of Mediastinal Metastasis in Patients with Non-small Cell Lung Cancer
Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival
The Role of Gefitinib Treatment for Korean Never-Smokers with Advanced or Metastatic Adenocarcinoma of the Lung: A Prospective Study
A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report
Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung Cancer
DHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter Trial
Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914
Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)
A Phase I Dose-Escalation Study of ZD6474 in Japanese Patients with Solid, Malignant Tumors
A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer
Brain: The Common Site of Relapse in Patients with Pancoast or Superior Sulcus Tumors
Early Detection of Bronchial Stump Insufficiency After Bilobectomy
Spontaneous Expectoration of Primary Pulmonary Synovial Sarcoma
Proteomic Strategies for the Characterization and the Early Detection of Lung Cancer
Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline